Mesenchymal Stem Cells Market to Grow with a CAGR of 8.54% through 2030F
Rising prevalence of
chronic diseases and the increasing investment in biotechnology are
factors driving the global Mesenchymal Stem Cells market in the forecast
period 2026-2030F
According to TechSci Research report, “Mesenchymal Stem Cells Market –
Global Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2030”, the Global Mesenchymal Stem Cells Market stood at USD
2.71 billion in 2024 and is anticipated to grow with a CAGR of 8.54% in the
forecast period, 2026-2030. The global Mesenchymal Stem Cells (MSCs) market has
been experiencing significant growth in recent years, driven by a combination
of factors that underscore the importance of regenerative medicine and
cell-based therapies. MSCs are multipotent adult stem cells with the ability to
differentiate into various cell types, making them a valuable resource in the
field of regenerative medicine.
The global population is aging at an unprecedented rate, leading to a surge in
age-related diseases and conditions such as osteoarthritis, Alzheimer's
disease, and heart disease. MSC-based therapies hold immense potential for
addressing age-related health issues by promoting tissue repair and
regeneration. As the elderly population continues to grow, the demand for
MSC-based treatments is expected to rise substantially.
Browse over XX market data Figures spread through XX Pages and an in-depth
TOC on "Global Mesenchymal Stem Cells Market”
One of the primary drivers of the global MSCs market is the increasing
prevalence of chronic diseases, including cardiovascular disorders, diabetes,
orthopedic conditions, and autoimmune diseases. MSC-based therapies offer the
potential to treat these diseases effectively. The regenerative capabilities of
MSCs can help repair damaged tissues and modulate the immune system, making
them a promising tool for addressing the growing burden of chronic illnesses.
The global population is
aging at an unprecedented rate, leading to a surge in age-related diseases and
conditions such as osteoarthritis, Alzheimer's disease, and heart disease.
MSC-based therapies hold immense potential for addressing age-related health
issues by promoting tissue repair and regeneration. As the elderly population
continues to grow, the demand for MSC-based treatments is expected to rise
substantially.
Advancements in cell
therapy research have propelled the development of innovative MSC-based
treatments. Researchers are continuously uncovering new applications for MSCs,
such as tissue engineering, wound healing, and immunomodulation. These
breakthroughs have expanded the market's potential, as pharmaceutical companies
and biotechnology firms invest in the development of novel therapies that
harness the therapeutic potential of MSCs.
Collaborations between
academic institutions, research organizations, and pharmaceutical companies
have become more common in the field of regenerative medicine. These
partnerships facilitate the exchange of knowledge, expertise, and resources,
leading to accelerated research and development efforts. Collaborative
initiatives are vital drivers of innovation and market growth in the MSCs
sector.
The Global Mesenchymal Stem Cells Market is segmented into product &
services, workflow, type, source of isolation, indication, application and
company.
Based on source of isolation,
bone marrow is the dominant source in the global mesenchymal stem cell (MSC)
market. This is primarily due to its long-established clinical use, high
concentration of MSCs, and extensive research supporting its efficacy and
safety in regenerative therapies. Bone marrow-derived MSCs have been widely
studied and applied in treating orthopedic, autoimmune, and neurodegenerative
disorders. Their well-characterized profile, strong clinical data, and
regulatory familiarity contribute to their leadership in the market.The
established harvesting techniques and widespread infrastructure in hospitals
and research institutions further support bone marrow’s continued dominance
over newer or less-characterized MSC sources like adipose tissue or cord blood.
Based on region, Asia-Pacific is the fastest-growing region in the global
mesenchymal stem cell (MSC) market due to a combination of supportive
government initiatives, increasing healthcare investments, and rising demand
for regenerative medicine. Countries like China, Japan, South Korea, and India
are actively investing in stem cell research and clinical trials. The region
also benefits from a large patient population, lower manufacturing costs, and
expanding biotechnology sectors. The favorable regulatory reforms and
collaborations between academic institutions and biotech firms are accelerating
innovation. These factors collectively drive rapid adoption and development of
MSC-based therapies, positioning Asia-Pacific as a key hub for market
expansion.
Major companies
operating in Global Mesenchymal Stem Cells Market are:
·
Thermo Fisher
Scientific, Inc
·
Cell Applications, Inc
·
Axol Biosciences Ltd
·
Cytori Therapeutics Inc
·
STEMCELL Technologies
·
Cyagen Biosciences
·
Celprogen Inc
·
BrainStorm Cell Limited
·
Stemedica Cell
Technologies Inc
·
Merck KGaA
(MilliporeSigma)
·
PromoCell GmbH
Download Free Sample Report
Customers can also
request 10% free customization on this report.
“The global Mesenchymal Stem Cells market is poised for substantial growth in
the coming years, thanks to a convergence of key market drivers. The rising
prevalence of chronic diseases, the aging population, advances in cell therapy
research, regulatory support, increasing investments in biotechnology, rising
patient awareness, and collaborative partnerships are all contributing to the
expansion of this dynamic market. As the therapeutic potential of MSCs
continues to be explored and realized, we can expect further advancements and
breakthroughs in the field of regenerative medicine, with significant benefits
for patients worldwide.,” said Mr. Karan Chechi, Research Director with TechSci
Research, a research-based management consulting firm.
“Mesenchymal Stem Cells Market, By Product & Services (Products(Cells
& Cell Lines, Kits, Media, & Reagents, Others), Services), By Workflow (Cell Sourcing & Isolation,
Culture & Cryopreservation, Differentiation, Characterization), By Type (
Autologous, Allogeneic), By Source of Isolation( Bone Marrow, Cord Blood,
Peripheral Blood, Fallopian Tube, Fetal Liver, Lung, Adipose Tissues), By
Indication (Bone And Cartilage Repair, Cardiovascular Disease, Inflammatory And
Immunological Diseases, Liver Diseases, Cancer, GvHD, Others), By Application (
Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue
Engineering, Toxicology Studies, Others), By Region & Competition, 2020-2030F”,
has evaluated the future growth potential of Global Mesenchymal Stem Cells
Market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Mesenchymal Stem
Cells Market.
Contact
Mr. Ken Mathews
TechSci Research LLC
420 Lexington Avenue,
Suite 300, New York,
United States- 10170
M: +13322586602
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com